Cargando…
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making
BACKGROUND: Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine stated practice across UK breast units, in terms of indications for use, radiologi...
Autores principales: | Whitehead, I., Irwin, G. W., Bannon, F., Coles, C. E., Copson, E., Cutress, R. I., Dave, R. V., Gardiner, M. D., Grayson, M., Holcombe, C., Irshad, S., O’Brien, C., O’Connell, R. L., Palmieri, C., Shaaban, A. M., Sharma, N., Singh, J. K., Potter, S., McIntosh, S. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825231/ https://www.ncbi.nlm.nih.gov/pubmed/33482770 http://dx.doi.org/10.1186/s12885-020-07757-6 |
Ejemplares similares
-
The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer
por: Irwin, G.W., et al.
Publicado: (2019) -
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022) -
Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022) -
The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol
por: Courtney, Alona, et al.
Publicado: (2020) -
Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study
por: Dave, Rajiv V., et al.
Publicado: (2021)